Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature Review.

Chernova P, Orlova M, Baryakh E, Misyurina E, Tolstykh T, Zotina E, Tyshkevich G, Basova V, Suvorina M, Misyurin A, Mingalimov M

Open source

DOI
10.3390/jcm15145558
Published
2026 Jul 15
Container
Journal of clinical medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm15145558,
  title = {Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature Review.},
  author = {Chernova P and Orlova M and Baryakh E and Misyurina E and Tolstykh T and Zotina E and Tyshkevich G and Basova V and Suvorina M and Misyurin A and Mingalimov M},
  year = {2026},
  journal = {Journal of clinical medicine},
  doi = {10.3390/jcm15145558},
  url = {https://doi.org/10.3390/jcm15145558}
}

RIS

TY  - JOUR
TI  - Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature Review.
AU  - Chernova P
AU  - Orlova M
AU  - Baryakh E
AU  - Misyurina E
AU  - Tolstykh T
AU  - Zotina E
AU  - Tyshkevich G
AU  - Basova V
AU  - Suvorina M
AU  - Misyurin A
AU  - Mingalimov M
PY  - 2026
JO  - Journal of clinical medicine
DO  - 10.3390/jcm15145558
UR  - https://doi.org/10.3390/jcm15145558
ER  - 

APA

P, C., M, O., E, B., E, M., T, T., E, Z., G, T., V, B., M, S., A, M., & M, M. (2026). Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature Review.. Journal of clinical medicine. https://doi.org/10.3390/jcm15145558

Source records